BridgeMD
New treatment option for Gastric (Cardia, Body) Cancer
Official title Quality of Life After Billroth II or Roux-en-Y for Gastric Cancer
ClinicalTrials.gov ID: NCT06768164
What this study is testing
- What it's testing
- The treatment of a local distal gastric cancer remains surgical before or after chemotherapy. Partial gastrectomy is recommended for distal location cancer The recommendations for restoring continuity are less evident.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients aged ≥ 18 years, men or women
- Patients treated for adenocarcinoma of the antrum accessible to a surgical treatment with curative intent by distal gastrectomy. If patients present...
- Patients with a registration in a national health care system (CMU included) (registered or being a beneficiary of such a scheme)
- Patients able to understand and fulfill questionnaires in French language
- Patients having given their written informed consent prior to participation in the study
You likely can't join if
- Patients with preoperative peritoneal metastasis or distant metastasis
- Palliative surgery patients
- Patients under tutorship or curatorship and protected adults
- Patients on AME (Aide Médicale de l'Etat = State Medical Assistance)
- Patients deprived of liberty by judicial or administrative decision and patients under psychiatric care (admitted to a health or social care...
- Patients unable to give their consent
See the full eligibility criteria
- Patients aged ≥ 18 years, men or women
- Patients treated for adenocarcinoma of the antrum accessible to a surgical treatment with curative intent by distal gastrectomy. If patients present a linitis plastica, negative proximal and distal margin will be...
- Patients with a registration in a national health care system (CMU included) (registered or being a beneficiary of such a scheme)
- Patients able to understand and fulfill questionnaires in French language
- Patients having given their written informed consent prior to participation in the study
- Patients with preoperative peritoneal metastasis or distant metastasis
- Palliative surgery patients
- Patients under tutorship or curatorship and protected adults
- Patients on AME (Aide Médicale de l'Etat = State Medical Assistance)
- Patients deprived of liberty by judicial or administrative decision and patients under psychiatric care (admitted to a health or social care establishment)
- Patients unable to give their consent
- Pregnant or breastfeeding women
- Women of childbearing age without effective contraception
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.